Minute Insight: Aignostics Completes Raise To Fund AI Pathology Platform
The company has raised €14m to develop its AI-based pathology software which will make diagnosing cancer faster and easier.
You may also be interested in...
Paige CEO Andy Moye talked to Medtech Insight about the company’s current offerings in the prostate and breast cancer markets, as well as its future ambitions and general strategy.
UK-based Quanta will use the proceeds to ramp up European commercialization and bring its SC+ portable hemodialysis system to US-based acute and chronic care facilities, but ultimately hopes to enter the rising US home-based dialysis market.
Hedera DX’s liquid biopsy test uses machine learning to recommend drugs to patients based on a tumor’s circulating DNA profile.